Identification | Back Directory | [Name]
1-(hydroxymethyl)cyclopropanecarbonitrile | [CAS]
98730-77-9 | [Synonyms]
1-(Hydroxymethyl) 1-methylolcyclopropane-1-carbonitrile -(hydroxymethyl)cyclopropanecarbonitrile 1-(hydroxymethyl)cyclopropanecarbonitrile cyclopropanecarbonitrile, 1-(hydroxymethyl)- 1-(hydroxyMethyl)cyclopropane-1-carbonitrile 1-(hydroxymethyl)-1-cyclopropanecarbonitrile | [Molecular Formula]
C5H7NO | [MDL Number]
MFCD11042632 | [MOL File]
98730-77-9.mol | [Molecular Weight]
97.12 |
Chemical Properties | Back Directory | [Boiling point ]
227.9±13.0 °C(Predicted) | [density ]
1.15±0.1 g/cm3(Predicted) | [storage temp. ]
2-8°C | [pka]
15.10±0.10(Predicted) | [Appearance]
Colorless to light yellow Liquid |
Hazard Information | Back Directory | [Synthesis]
The general procedure for the synthesis of 1-(hydroxymethyl)cyclopropanecarbonitrile from ethyl 1-cyanocyclopropanecarboxylate was as follows: LiBH4 (573 mg, 26.3 mmol, 2 equiv.) was added to a solution of 1-cyanocyclopropanecarboxylic acid ethyl ester (1.7 mL, 13.15 mmol, 1 equiv.) in tetrahydrofuran (THF, 18 mL). The reaction mixture was heated to 50 °C and kept at this temperature for 18 hours. Upon completion of the reaction, the mixture was cooled to 0 °C and saturated aqueous NaHCO3 solution was slowly added until gas escape ceased. Subsequently, the reaction mixture was diluted with brine (20 mL) and extracted sequentially with ethyl acetate (EtOAc, 1 × 60 mL), dichloromethane (DCM, 3 × 60 mL) and 10% methanol/DCM solution (2 × 60 mL). All organic extracts were combined, dried with anhydrous magnesium sulfate (MgSO4), and concentrated under reduced pressure to remove the solvent, to afford 1-(hydroxymethyl)cyclopropanecarbonitrile as a clear oil (820 mg, 65% yield). The product was characterized by 1H NMR (500 MHz, CDCl3): δ 0.96-1.01 (2H, m), 1.27-1.31 (2H, m), 3.64 (2H, s). | [References]
[1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 6, p. 1797 - 1801 [2] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 19, p. 8922 - 8931 [3] Patent: WO2017/55860, 2017, A1. Location in patent: Page/Page column 183; 184 [4] Patent: WO2005/63247, 2005, A1. Location in patent: Page/Page column 78 [5] Patent: WO2010/25179, 2010, A1. Location in patent: Page/Page column 22 |
|
Company Name: |
Tetranov Biopharm
|
Tel: |
13526569071 |
Website: |
http://www.leadmedpharm.com/index.html |
|